18th International Diabetes Federation Congress, Paris Estimations of the clinical benefit of optimal blood glucose, blood pressure and lipid control in type 2 diabetic patients with the metabolic syndrome
Koro CE, Bowlin S, Sun Y, Gomez-Camineros A, the ADOPT Study Group
Diabetologia 2003;46:Suppl 2:A76 [Abstract]
18th International Diabetes Federation Congress, Paris Differences in the prevalence of the metabolic syndrome between ethnic groups in recently diagnosed type 2 diabetes in the North American cohort of the ADOPT study
Haffner SM, Zinman B, Kahn SE, Herman WH, Heise MA, O'Neill MC, Porter LE, the ADOPT Study Group
Diabetologia 2003;46:suppl 2:A144 [Abstract]
18th International Diabetes Federation Congress, Paris Symptoms and health status in a recently-diagnosed type 2 diabetic population: the ADOPT study
Perry A, Herman W, Freed MI, Heise MA, Kravitz B, the ADOPT Study Group
Diabetes Metabolism 2003;29:4S16-4S17 [Abstract]
18th International Diabetes Federation Congress, Paris Are different clinical practice guidelines associated with regional differences in diabetes care?
Herman WH, Kravitz B, Sun Y, the ADOPT Study Group
Diabetologia 2003;46:suppl 2:A436 [Abstract]
18th International Diabetes Federation Congress, Paris Prevalence and clinical significance of glutamic acid decarboxylase (GAD) antibodies in recently diagnosed type 2 diabetes in the ADOPT study cohort.
Zinman B, Kahn SE, Haffner SM, Herman W, Heise MA, O'Neill MC, the ADOPT Study Group
Diabetologia 2003;46:suppl 2:A148 [Abstract]
18th International Diabetes Federation Congress, Paris Prevalence of microalbuminuria in recently diagnosed type 2 diabetes mellitus and its relationship to non-traditional risk factors: observations from the ADOPT study
Viberti G, Freed MI, Holman R, Lachin J, Heise MA, the ADOPT Study Group
Diabetologia 2003;46:suppl 2:A326 [Abstract]
18th International Diabetes Federation Congress, Paris Lack of concordance of WHO and NCEP criteria for the diagnosis of the metabolic syndrome in recently diagnosed diabetes in North America and Europe in the ADOPT study cohort
Kahn SE, Haffner SM, Zinman B, Heise MA, O'Neill MC, Porter LE, the ADOPT Study Group
Diabetes Metabolism 2003;29:4S32 [Abstract]
18th International Diabetes Federation Congress, Paris Levels of beta-cell dysfunction and insulin resistance differ between Europeans and North Americans with recently-diagnosed diabetes in the ADOPT study
Holman RR, Kahn SE, Heise MA, Porter LE, Freed MI, the ADOPT Study Group
Diabetologia 2003;46:suppl 2:A198 [Abstract]
63rd Scientific Sessions of the American Diabetes Association, New Orleans Ethnic differences in the prevalence of the metabolic syndrome in recently diagnosed type 2 diabetes in the North American cohort of the ADOPT study
Haffner SM, Zinman B, Kahn SE, Herman WH, Heise MA, O'Neill MC, Porter LE, the ADOPT Study Group
Diabetes 2003;52:suppl:A220 [Abstract]
63rd Scientific Sessions of the American Diabetes Association, New Orleans Lack of concordance of NCEP and WHO criteria for the diagnosis of the metabolic syndrome in recently diagnosed diabetes in North America and Europe in the ADOPT study cohort
Kahn SE, Haffner SM, Zinman B, Heise MA, O'Neill MC, Porter LE, the ADOPT Study Group
Diabetes 2003;52:suppl:A222 [Abstract]
63rd Scientific Sessions of the American Diabetes Association, New Orleans Prevalence of microalbuminuria and its relationship to non-traditional risk factors in recently diagnosed type 2 diabetes mellitus: observations from the ADOPT study
Viberti G, Freed MI, Holman R, Lachin J, Heise MA, the ADOPT Study Group
Diabetes 2003;52:suppl:A190 [Abstract]
63rd Scientific Sessions of the American Diabetes Association, New Orleans Prevalence and clinical significance of glutamic acid decarboxylase (GAD) antibodies in recently diagnosed type 2 diabetes in the ADOPT study cohort
Zinman B, Kahn SE, Haffner SM, Herman W, Heise MA, O'Neill MC, the ADOPT Study Group
Diabetes 2003;52:suppl:A233 [Abstract]
63rd Scientific Sessions of the American Diabetes Association, New Orleans The ADOPT study: symptoms and health status in a recently diagnosed type 2 diabetic population
Herman W, Freed MI, Heise MA, Kravitz B, Perry A, the ADOPT Study Group
Diabetes 2003;52:suppl:A263 [Abstract]
63rd Scientific Sessions of the American Diabetes Association, New Orleans Risk of Heart Failure in Type 2 Diabetes
Coleman R, Stevens RJ, Stratton IM, Adler A, Matthews D, Holman RR
Diabetes 2003;52:Suppl 1:A217
60th Scientific Sessions of the American Diabetes Association, Glasgow Six-year results from the Early Diabetes Intervention Trial
Holman RR, Blackwell L, Stratton IM, Manley SE, Tucker L, Frighi V
Diabetic Medecine 2003;20:(Suppl 2):15 [Abstract]
Diabetes Trials Unit, OCDEM, Churchill Hospital, Old Road, Headington, Oxford, OX3 7LJ
Tel: +44 (0)1865 857242 Email: dtu@dtu.ox.ac.uk